lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Expression and regulation

Regulation From TransFac database

USF2(h) --> HOXB4(h) (DNA binding).
USF2(h) --> E2L(AD2) (DNA binding).
c-Fos(h) + USF2(h) <==> c-Fos(h):USF2(h) (binding).
USF2(h) + USF(SP) <==> USF2(h):USF(SP) (binding).
USF2(h) + usf1(h) <==> USF2(h):usf1(h) (binding)
USF2(h) + USF2(r) <==> USF2(h):USF2(r) (binding).
USF2(h) + USF2(h) <==> USF2(h):USF2(h) (binding).
USF2(h) --> TFF2(h) (DNA binding; transactivation)
USF2(h) --> GLI1(h) (DNA binding).
USF2(h) --> PIGR(h) (DNA binding; transactivation).
USF2(h) + brca1(h) <==> brca1(h):USF2(h) (binding)
USF2(h) --> TERT(h) (DNA binding; transactivation).
USF2(h) --> PIGR(m) (DNA binding; transactivation).
USF2(h) --> CYP19A1(h) (DNA binding).
USF2(h) --> PTGS2(h) (DNA binding).
USF2(h) --> Fmr1(m) (DNA binding).
USF2(h) --> AVP(h) (DNA binding).
USF2(h) --> BRCA2(h) (DNA binding; transactivation).
USF2(h) --> Pf4(r) (DNA binding).
USF2(h) --> PF4(h) (DNA binding).
USF2(h) + survivin(h) <==> USF2(h):survivin(h) (binding)
USF2(h) + SCCA1(h) <==> USF2(h):SCCA1(h) (binding)
USF2(h) + MRP-14(h) <==> USF2(h):MRP-14(h) (binding)
USF2(h) + SCCA2(h) <==> USF2(h):SCCA2(h) (binding)
USF2(h) + APG1(h) <==> USF2(h):APG1(h) (binding)
USF2(h) + PRL-2(h) <==> USF2(h):PRL-2(h) (binding)
USF2(h) + MRP-8(h) <==> USF2(h):MRP-8(h) (binding)
USF2(h) + nucleophosmin(h) <==> USF2(h):nucleophosmin(h) (binding)
USF2(h) + TLS(h) <==> USF2(h):TLS(h) (binding)
USF2(h) --> Lgals3bp(r) (transactivation)
USF2(h) --> HMOX1(h) (DNA binding).
USF2(h) --> Apoa5(h) (DNA binding).
USF2(h) --> ASPH(h) (DNA binding).
USF2(h) --> ACACA(s) (DNA binding).
USF2(h) --> APLN(h) (transactivation)
USF2(h) --> Apln(r) (transactivation)
USF2(h) --> Nr5a1(m) (DNA binding).
USF2(h) --> Serpine1(r) (transactivation)
USF2(h) --> SERPINE1(h) (DNA binding; transactivation).
USF2(h) --> UGT1A1(h) (DNA binding).
USF2(h) --> USF2(h) (expression).
USF2b(h) --> Pklr(r) (DNA binding; transregulation).
USF2b(h) --> E2L(AD2) (DNA binding).
USF2b(h) --> MLP(AD) (DNA binding).
USF2b(h) --> APP(h) (DNA binding).
USF2b(h) + usf1(h) <==> USF2b(h):usf1(h) (binding).
USF2(h) --> USF2b(h) (expression).
USF2a(h) --> Pklr(r) (DNA binding; transregulation).
USF2a(h) --> CXCR4(h) (DNA binding).
USF2a(h) --> MLP(AD) (DNA binding).
USF2a(h) --> APP(h) (DNA binding).
USF2a(h) --> APOA2(h) (DNA binding; transactivation).
USF2a(h) --> apoCIII(h) (DNA binding; transactivation).
USF2a(h) --> IGF2R(h) (DNA binding).
USF2a(h) --/ Serpine1(r) (DNA binding; transrepression).
USF2a(h) --> CHI3L1(h) (DNA binding).
USF2(h) --> USF2a(h) (expression).
USF2(h) --> USF2A-delta-H(h) (expression).
USF2(h) --> USF2(h) (expression).
hsa-miR-10a --/ USF2(h) (increase of mRNA decay).

Human Primary Tumor Samples (U95)  | Top

Click to view sample information

Human U133A/GNF1H Gene Atlas  | Top